Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 2/2022

15.10.2022 | COVID-19 | Clinical Report

Wave of Invasive Fungal Disease on the Shores of COVID-19: A Case Series of COVID-19 Associated Rhino-Orbital Fungal Rhinosinusitis and Literature Review

verfasst von: Sandeep Trehan, Neena Chaudhary, Ashwin Bhasarkar

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Coronavirus disease 2019 (COVID-19) may be associated with a wide range of bacterial and fungal co-infections. Acute invasive fungal sinusitis is an aggressive infection affecting immunocompromised patients and high mortality rate. Here, in this case series, we have reviewed three cases of COVID-19 associated rhino-orbital invasive fungal disease. Patients with COVID-19 associated pneumonia with diabetes mellitus are at an increased risk of developing invasive pulmonary fungal infections probably due to their reduced immunological competence. Concurrent glucocorticoid therapy probably heightens the risk of mucormycosis. Physicians should be aware of and should have high index of suspicion of possible fungal infection in post COVID-19 patients. Aggressive management both medical and surgical, is required to improve outcomes of secondary invasive fungal infections in patients with COVID-19 infection.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Prenissl J, Jaacks LM, Mohan V et al (2019) Variation in health system performance for managing diabetes among states in India: a cross-sectional study of individuals aged 15 to 49 years. BMC Med 17:92CrossRefPubMedPubMedCentral Prenissl J, Jaacks LM, Mohan V et al (2019) Variation in health system performance for managing diabetes among states in India: a cross-sectional study of individuals aged 15 to 49 years. BMC Med 17:92CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Lim S, Bae JH, Kwon HS et al (2021) COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 17:11–30CrossRefPubMed Lim S, Bae JH, Kwon HS et al (2021) COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 17:11–30CrossRefPubMed
3.
Zurück zum Zitat Alanio A, Dellière S, Fodil S, Bretagne S, Mégarbane B (2020) Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med 8(6):e48–e49CrossRefPubMed Alanio A, Dellière S, Fodil S, Bretagne S, Mégarbane B (2020) Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med 8(6):e48–e49CrossRefPubMed
4.
Zurück zum Zitat Chakrabarti A, Kaur H, Savio J et al (2019) Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study). J Crit Care 51:64–70CrossRefPubMed Chakrabarti A, Kaur H, Savio J et al (2019) Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study). J Crit Care 51:64–70CrossRefPubMed
7.
Zurück zum Zitat Placik DA, Taylor WL, Wnuk NM (2020) Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia. Radiol Case Rep 15(11):2378–2381CrossRefPubMedPubMedCentral Placik DA, Taylor WL, Wnuk NM (2020) Bronchopleural fistula development in the setting of novel therapies for acute respiratory distress syndrome in SARS-CoV-2 pneumonia. Radiol Case Rep 15(11):2378–2381CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Monte Junior ESD, Santos M, Ribeiro IB, Luz GO, Baba ER, Hirsch BS et al (2020) Rare and fatal gastrointestinal mucormycosis (Zygomycosis) in a COVID-19 patient: a case report. Clin Endosc 53(6):746–749CrossRefPubMedPubMedCentral Monte Junior ESD, Santos M, Ribeiro IB, Luz GO, Baba ER, Hirsch BS et al (2020) Rare and fatal gastrointestinal mucormycosis (Zygomycosis) in a COVID-19 patient: a case report. Clin Endosc 53(6):746–749CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Group WHOREAfC-TW, Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J et al (2020) Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19 a meta-analysis. JAMA 324(13):1330–13341CrossRef Group WHOREAfC-TW, Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J et al (2020) Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19 a meta-analysis. JAMA 324(13):1330–13341CrossRef
13.
Zurück zum Zitat Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (2020) Features, evaluation and treatment coronavirus (COVID-19). Statpearls [internet]. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (2020) Features, evaluation and treatment coronavirus (COVID-19). Statpearls [internet].
14.
Zurück zum Zitat Beigel JH, Tomashek KM, Dodd LE et al (2020) Remdesivir for the treatment of COVID-19—Final Report. N Engl J Med 383(19):1813–1826CrossRefPubMed Beigel JH, Tomashek KM, Dodd LE et al (2020) Remdesivir for the treatment of COVID-19—Final Report. N Engl J Med 383(19):1813–1826CrossRefPubMed
15.
Zurück zum Zitat The WHO Rapid Evidence Appraisal for COVID-19 Therapies Working Group (2020) Association between administration of systemic corticosteroids and mortality among critically Ill patients With COVID-19: a meta-ANALYSIS. JAMA 324(13):1330–1341CrossRef The WHO Rapid Evidence Appraisal for COVID-19 Therapies Working Group (2020) Association between administration of systemic corticosteroids and mortality among critically Ill patients With COVID-19: a meta-ANALYSIS. JAMA 324(13):1330–1341CrossRef
16.
Zurück zum Zitat RECOVERY Collaborative Group (2021) Dexamethasone in hospitalized patients with COVID-19. N Engl J Med 384(8):693–704CrossRef RECOVERY Collaborative Group (2021) Dexamethasone in hospitalized patients with COVID-19. N Engl J Med 384(8):693–704CrossRef
17.
Zurück zum Zitat Huang I, Lim MA, Pranata R (2020) Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia—a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 14(4):395–403CrossRefPubMedPubMedCentral Huang I, Lim MA, Pranata R (2020) Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia—a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr 14(4):395–403CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Donnelly JP, Chen SC, Kauffman CA et al (2020) Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis : An Off Publ Infect Dis Soc Am 71(6):1367–1376CrossRef Donnelly JP, Chen SC, Kauffman CA et al (2020) Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis : An Off Publ Infect Dis Soc Am 71(6):1367–1376CrossRef
19.
Zurück zum Zitat Afroze SN, Korlepara R, Rao GV, Madala J (2017) Mucormycosis in a diabetic patient: a case report with an Insight into Its pathophysiology. Contemp Clin Dent 8(4):662–666CrossRefPubMedPubMedCentral Afroze SN, Korlepara R, Rao GV, Madala J (2017) Mucormycosis in a diabetic patient: a case report with an Insight into Its pathophysiology. Contemp Clin Dent 8(4):662–666CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Chen G, Wu D, Guo W et al (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Investig 130(5):2620–2629CrossRefPubMedPubMedCentral Chen G, Wu D, Guo W et al (2020) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Investig 130(5):2620–2629CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Clancy CJ, Nguyen MH (2020) Coronavirus disease 2019, superinfections, and antimicrobial development: What can we expect? Clin Infect Dis 71(10):2736–2743CrossRefPubMed Clancy CJ, Nguyen MH (2020) Coronavirus disease 2019, superinfections, and antimicrobial development: What can we expect? Clin Infect Dis 71(10):2736–2743CrossRefPubMed
Metadaten
Titel
Wave of Invasive Fungal Disease on the Shores of COVID-19: A Case Series of COVID-19 Associated Rhino-Orbital Fungal Rhinosinusitis and Literature Review
verfasst von
Sandeep Trehan
Neena Chaudhary
Ashwin Bhasarkar
Publikationsdatum
15.10.2022
Verlag
Springer India
Schlagwort
COVID-19
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 2/2022
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-022-03213-y

Weitere Artikel der Sonderheft 2/2022

Indian Journal of Otolaryngology and Head & Neck Surgery 2/2022 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.